Clinical Trial Update: Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes [Phase 4]

View source ↗

Summary

This Phase 4 trial update compares meal-time insulin dosing strategies in cystic fibrosis-related diabetes to assess safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis-related Diabetes

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Jagdeesh Ullal | Conditions: Cystic Fibrosis-related Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2025-03-19